210 results on '"Monaghan, Tanya M"'
Search Results
52. Changes in IgA-targeted microbiota following fecal transplantation for recurrent Clostridioides difficile infection.
53. Understanding the mechanisms of efficacy of fecal microbiota transplant in treating recurrent Clostridioides difficile infection and beyond: the contribution of gut microbial-derived metabolites.
54. Metagenomics reveals impact of geography and acute diarrheal disease on the Central Indian human gut microbiome.
55. High prevalence of subclass-specific binding and neutralizing antibodies against Clostridium difficile toxins in adult cystic fibrosis sera: possible mode of immunoprotection against symptomatic C. difficile infection
56. Orbital Inflammatory Complications of Crohn’s Disease: A Rare Case Series
57. Potential of lactoferrin to prevent antibiotic-induced Clostridium difficile infection
58. Profiling Humoral Immune Responses to Clostridium difficile-Specific Antigens by Protein Microarray Analysis
59. Pathogenesis of Clostridium difficile Infection and Its Potential Role in Inflammatory Bowel Disease
60. Circulating Antibody and Memory B-Cell Responses to C. difficile Toxins A and B in Patients with C. difficile-Associated Diarrhoea, Inflammatory Bowel Disease and Cystic Fibrosis
61. Tu1703 Characterization of Humoral Immune Responses to C.difficile Toxins a and B in Patients With C. difficile-Associated Diarrhoea, Inflammatory Bowel Disease and Cystic Fibrosis
62. Varicella Pneumonia in an Immunocompromised Inflammatory Bowel Disease Patient
63. A patient with neuro-Behçet's disease is successfully treated with etanercept: Further evidence for the value of TNFα blockade
64. Understanding the mechanisms of efficacy of fecal microbiota transplant in treating recurrent Clostridioides difficileinfection and beyond: the contribution of gut microbial-derived metabolites
65. Effective fecal microbiota transplantation for recurrent Clostridioides difficile infection in humans is associated with increased signalling in bile acid-farnesoid X receptor-fibroblast growth factor pathway
66. High prevalence of Clostridium difficile Ribotype 078 in IBD outpatients
67. Serum trace metal concentrations in Clostridium difficile infection and their relationship to disease severity
68. Novel lactoferrin-loaded alginate microbeads display anti-Clostridium difficile defence properties
69. A protein microarray assay for serological determination of antigen-specific antibody responses following Clostridium difficile infection
70. Orbital inflammatory complications of Crohn’s disease: a rare case series
71. Protective antibodies against Clostridium difficile are present in intravenous immunoglobulin and are retained in humans following its administration
72. High prevalence of subclass-specific binding and neutralizing antibodies against Clostridium difficile toxins in adult cystic fibrosis sera: possible mode of immunoprotection against symptomatic C. difficile infection
73. Profiling humoral immune responses to Clostridium difficile-specific antigens by protein microarray analysis
74. Profiling humoral immune responses to Clostridium difficile-specific antigens by protein microarray analysis
75. Circulating antibody and memory B-cell responses to C. difficile toxins A and B in patients with C. difficile- associated diarrhoea, inflammatory bowel disease and cystic fibrosis
76. High prevalence of Clostridium difficile Ribotype 078 in IBD outpatients
77. Novel lactoferrin-loaded alginate microbeads display anti-Clostridium difficile defence properties
78. Effective fecal microbiota transplantation for recurrent Clostridioides difficile infection in humans is associated with increased signalling in bile acid-farnesoid X receptor-fibroblast growth factor pathway
79. Serum trace metal concentrations in Clostridium difficile infection and their relationship to disease severity
80. A protein microarray assay for serological determination of antigen-specific antibody responses following Clostridium difficile infection
81. High prevalence of subclass-specific binding and neutralizing antibodies against Clostridium difficile toxins in adult cystic fibrosis sera: possible mode of immunoprotection against symptomatic C. difficile infection
82. Orbital inflammatory complications of Crohn’s disease: a rare case series
83. Protective antibodies against Clostridium difficile are present in intravenous immunoglobulin and are retained in humans following its administration
84. Profiling humoral immune responses to Clostridium difficile-specific antigens by protein microarray analysis
85. Circulating antibody and memory B-cell responses to C. difficile toxins A and B in patients with C. difficile- associated diarrhoea, inflammatory bowel disease and cystic fibrosis
86. Profiling humoral immune responses to Clostridium difficile-specific antigens by protein microarray analysis
87. Novel lactoferrin-loaded alginate microbeads display anti-Clostridium difficile defence properties
88. Serum trace metal concentrations in Clostridium difficile infection and their relationship to disease severity
89. High prevalence of Clostridium difficile Ribotype 078 in IBD outpatients
90. Effective fecal microbiota transplantation for recurrent Clostridioides difficile infection in humans is associated with increased signalling in bile acid-farnesoid X receptor-fibroblast growth factor pathway
91. A protein microarray assay for serological determination of antigen-specific antibody responses following Clostridium difficile infection
92. Orbital inflammatory complications of Crohn’s disease: a rare case series
93. High prevalence of subclass-specific binding and neutralizing antibodies against Clostridium difficile toxins in adult cystic fibrosis sera: possible mode of immunoprotection against symptomatic C. difficile infection
94. Protective antibodies against Clostridium difficile are present in intravenous immunoglobulin and are retained in humans following its administration
95. Novel lactoferrin-loaded alginate microbeads display anti-Clostridium difficile defence properties
96. High prevalence of Clostridium difficile Ribotype 078 in IBD outpatients
97. Serum trace metal concentrations in Clostridium difficile infection and their relationship to disease severity
98. Effective fecal microbiota transplantation for recurrent Clostridioides difficile infection in humans is associated with increased signalling in bile acid-farnesoid X receptor-fibroblast growth factor pathway
99. A protein microarray assay for serological determination of antigen-specific antibody responses following Clostridium difficile infection
100. Orbital inflammatory complications of Crohn’s disease: a rare case series
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.